The Journal of Antibiotics · 2019 · 19 citations · 22 references
PharmacyMedicinal ChemistryMicrobiologyAntimicrobial ResistanceBioisosterismDrug DiscoveryAntibacterial PharmacologyAntibiotic ResistanceMultidrug ResistanceAmide Bond FormationAntibiotic DiscoveryCoenzyme A BiosynthesisMultidrug-resistant OrganismsMultidrug-resistant PathogensNovel Antibacterial AgentsNovel Antibacterial Drug Discovery
The emergence of multidrug resistant bacteria has prioritized the development of new antibiotics. N-substituted pantothenamides, analogs of the natural compound pantetheine, were reported to target bacterial coenzyme A biosynthesis, but these compounds have never reached the clinic due to their instability in biological fluids. Plasma-stable pantothenamide analogs could overcome these issues. We first synthesized a number of bioisosteres of the prototypic pantothenamide N7-Pan. A compound with an inverted amide bond (CXP18.6-012) was found to provide plasma-stability with minimal loss of activity compared to the parent compound N7-Pan. Next, we synthesized inverted pantothenamides with a large variety of side chains. Among these we identified a number of novel stable inverted pantothenamides with selective activity against Gram-positive bacteria such as staphylococci and streptococci, at low micromolar concentrations. These data provide future direction for the development of pantothenamides with clinical potential.
22
Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens
Sophie Brinster, Gilles Lamberet, Bart Staels et al. · Nature · 2009 · 324 citations
Nachum Kaplan, Monique Albert, Donald E. Awrey et al. · Antimicrobial Agents and Chemotherapy · 2012 · 113 citations · Full text